Hypothesis

Age‑related shifts in the gut microbiome alter the diurnal pattern of secondary bile acids, which then activate vagal afferents expressing TGR5 and trigger hippocampal TGF‑β/SMAD3 signaling that deposits repressive histone marks on plasticity genes, driving memory decline.

Mechanistic Rationale

The gut microbiota produces secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) in a circadian‑dependent manner[https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1362239/full]. In young hosts, these metabolites peak during the active phase and bind TGR5 on enterochromaffin cells, stimulating serotonin release that fine‑tunes vagal tone. With aging, microbial 7α‑dehydroxylase activity becomes constitutively high, flattening the bile acid oscillation and elevating circulating DCA/LCA even during the rest phase[https://doi.org/10.1101/2024.06.16.599193]. Persistent TGR5 activation on vagal afferents leads to chronic calcium influx, which activates upstream TGF‑β1 release from resident macrophages in the nodose ganglion[https://pubmed.ncbi.nlm.nih.gov/38350490/]. Vagal efferents then convey this signal to the hippocampus, where TGF‑β/SMAD3 signaling recruits HDAC2 and SUV39H1, causing H3K9 trimethylation and reduced expression of Bdnf and Synapsin1[https://www.pnas.org/doi/10.1073/pnas.1508249112]. The resulting epigenetic silencing weakens long‑term potentiation and manifests as memory loss, independent of peripheral inflammation.

Testable Predictions

1. Aged mice will show a loss of diurnal variation in fecal DCA/LCA concentrations compared with young mice.
2. Pharmacological neutralization of DCA/LCA (using cholestyramine) or genetic ablation of microbial 7α‑dehydroxylase (Δbai operon) will restore bile acid rhythmicity and prevent hippocampal H3K9me3 increase, even if overall dysbiosis persists.
3. Vagotomy or selective TGR5 antagonism in vagal afferents will block TGF‑β/SMAD3 activation in the hippocampus and rescue memory performance in aged mice despite elevated bile acids.
4. Transplanting feces from aged donors with knocked‑out bai genes into germ‑free young recipients will not transfer the memory deficit, whereas wild‑type aged feces will.

Experimental Design

• Longitudinal metabolomics: Collect fecal samples every 4 h over 48 h from 3‑month and 24‑month mice; quantify DCA/LCA via LC‑MS/MS[https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1362239/full].
• Intervention groups: (a) aged controls, (b) aged + cholestyramine, (c) aged + vagal TGR5 antagonist (SBR‑AG‑030), (d) aged + bacteriophage targeting bai‑expressing strains, (e) sham.
• Readouts: Hippocampal H3K9me3 and H3K27ac ChIP‑qPCR for Bdnf promoter; electrophysiological LTP in slices; novel object recognition memory; vagal nerve activity recorded via extracellular electrophysiology.
• Controls: Germ‑free mice colonized with either wild‑type aged microbiota or bai‑deficient aged microbiota to isolate metabolite effects.

Potential Outcomes

If predictions hold, the data will support a model where microbial bile acid arrhythmicity, rather than bulk inflammation, directly reprograms hippocampal epigenetics via a vagus‑TGF‑β axis. Failure to rescue memory by bile acid neutralization or vagal TGR5 blockade would falsify the hypothesis and suggest alternative mediators (e.g., microbial D‑amino acids or peptidoglycan fragments) drive the gut‑brain aging signal.

Implications

Targeting microbial bile acid enzymology or vagal TGR5 signaling offers a precise, chronobiological strategy to preserve hippocampal epigenetics during aging, complementing broad‑spectrum approaches like fecal transplantation or time‑restricted feeding.